From: A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy
Baseline IOP (mmHg)
IOP at 1wk (mmHg)
IOP at 6 months (mmHg)
VA group
15.83 ± 2.36
21.67 ± 10.39ab
16.22 ± 2.86
TA group
16.44 ± 1.50
18.14 ± 9.50
16.57 ± 2.24
BSS group
15.81 ± 1.86
16.22 ± 6.22
16.44 ± 2.17